Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated and other comprehensive loss	Total
Balances, Beginning at Dec. 31, 2022	$ 207	$ 545,362	$ (436,182)	$ (207)	$ 109,180
Balances, Beginning (in shares) at Dec. 31, 2022	20,663,736
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 1	727			$ 728
Exercise of stock options (in shares)	144,187				144,187
Proceeds from Employee Stock Purchase Plan	$ 1	934			$ 935
Proceeds from Employee Stock Purchase Plan (shares)	71,276
Employee stock compensation		6,303			6,303
Net Income (Loss)			(41,199)		(41,199)
Balances, Ending at Dec. 31, 2023	$ 209	553,326	(477,381)	(207)	75,947
Balances, Ending (in shares) at Dec. 31, 2023	20,879,199
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 5	2,693			$ 2,698
Exercise of stock options (in shares)	510,669				510,669
Proceeds from Employee Stock Purchase Plan	$ 1	802			$ 803
Proceeds from Employee Stock Purchase Plan (shares)	79,618
Employee stock compensation		19,050			19,050
Issuance of common stock, net of costs	$ 32	32,489			32,521
Issuance of common stock, net of costs (in shares)	3,251,198
Issuance of common stock upon net exercise of common warrants	$ 6	(6)
Issuance of common stock upon net exercise of common warrants (in shares)	604,000
Net Income (Loss)			(59,965)		(59,965)
Cumulative translation adjustment				1	1
Balances, Ending at Dec. 31, 2024	$ 253	$ 608,354	$ (537,346)	$ (206)	$ 71,055
Balances, Ending (in shares) at Dec. 31, 2024	25,324,684